Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects

Abstract

Background Schizophrenia is associated with immune system dysfunction, including aberrant cytokine levels. We performed a meta-analysis of these associations, considering effects of clinical status and antipsychotic treatment following an acute illness exacerbation. Methods We identified articles by searching PubMed, PsychInfo, and Institute for Scientific Information and the reference lists of identified studies. Results Forty studies met the inclusion criteria. Effect sizes were similar for studies of acutely relapsed inpatients (AR) and first-episode psychosis (FEP). Interleukin (IL)-1β, IL-6, and transforming growth factor-β (TGF-β) appeared to be state markers, as they were increased in AR and FEP (p.001 for each) and normalized with antipsychotic treatment (p.001, p.008, and p.005, respectively). In contrast, IL-12, interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), and soluble IL-2 receptor (sIL-2R) appeared to be trait markers, as levels remained elevated in acute exacerbations and following antipsychotic treatment. There was no difference in IL-6 levels between stable medicated outpatients and control subjects (p.69). In the cerebrospinal fluid, IL-1β was significantly decreased in schizophrenia versus controls (p.01). Conclusions Similar effect sizes in AR and FEP suggest that the association between cytokine abnormalities and acute exacerbations of schizophrenia is independent of antipsychotic medications. While some cytokines (IL-1β, IL-6, and TGF-β) may be state markers for acute exacerbations, others (IL-12, IFN-γ, TNF-α, and sIL-2R) may be trait markers. Although these results could provide the basis for future hypothesis testing, most studies did not control for potential confounding factors such as body mass index and smoking.

Tryptophan Metabolism and White Matter Integrity in Schizophrenia

“…The causes of white matter abnormalities in schizophrenia remain unclear. One of the possibilities explaining the link between tryptophan level and FA may in part be related to evidence of chronic inflammation in schizophrenia (Miller et al, 2011;Upthegrove et al, 2014). Proinflammatory cytokines, interferon-γ in particular, upregulate IDO, one of the ratelimiting enzymes involved in conversion of tryptophan to kynurenine .…”

Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data

“…A wealth of data has demonstrated higher levels of proinflammatory markers, such as cytokines, in cerebrospinal fluid and plasma in patients across disease stages of schizophrenia (3,47). In the brain, these signaling molecules are mainly released by microglia and astrocytes, which have key roles in the immune response (9).…”

Purinergic mechanisms in neuroinflammation: An update from molecules to behavior

“…As for BPD, peripheral IL-2, IL-4 and IL-6 are found to be increased in manic episodes (Brietzke et al, 2011) whereas another meta-analysis revealed significant elevation of soluble interleukin (IL)-2 receptor (sIL-2R), TNF-a, soluble tumor necrosis factor receptor type 1 (sTNFR1) and soluble interleukin (IL)-6 receptor (sIL-6R) (Munkholm et al, 2013). In the case of schizophrenia, TNF-a, IFN-g, IL-12 and IL-2 are consistently elevated in chronic schizophrenic patients, while IL-1b, IL-6 and TGF-b correlate positively with disease activity (Miller et al, 2011).…”